Assenagon Asset Management
FOLD

Assenagon Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Assenagon Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,848,454
Closed -$14.6M – 1191
2025
Q3 		$14.6M Sell
1,848,454
-1,685,400
-48% -$12M 0.02% 419
2025
Q2 		$20.2M Buy
3,533,854
+3,057,072
+641% +$19.7M 0.03% 347
2025
Q1 		$3.89M Hold
476,782
– – 0.01% 584
2024
Q4 		$4.49M Sell
476,782
-1,561,114
-77% -$16.2M 0.01% 710
2024
Q3 		$21.8M Buy
2,037,896
+1,192,489
+141% +$13M 0.04% 324
2024
Q2 		$8.39M Buy
+845,407
New +$8.68M 0.02% 480
2020
Q3 		– Sell
-1,583,568
Closed -$23.9M – 1204
2020
Q2 		$23.9M Buy
1,583,568
+301,513
+24% +$3.67M 0.15% 93
2020
Q1 		$11.8M Buy
1,282,055
+553,971
+76% +$5.27M 0.09% 155
2019
Q4 		$7.09M Buy
728,084
+487,774
+203% +$4.47M 0.04% 208
2019
Q3 		$1.93M Buy
+240,310
New +$2.61M 0.01% 409
2019
Q2 		– Sell
-2,872,378
Closed -$39.1M – 1048
2019
Q1 		$39.1M Buy
2,872,378
+2,101,069
+272% +$25.7M 0.37% 61
2018
Q4 		$7.39M Buy
+771,309
New +$8.48M 0.08% 183

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Assenagon Asset Management's FOLD Position: Q4 2025 in Review

Assenagon Asset Management sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 1,848,454 shares — an estimated $14.6M sold.

Assenagon Asset Management first reported a position in FOLD in Q4 2018 and held it in 12 quarters. The position peaked at $39.1M in Q1 2019. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Assenagon Asset Management reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Assenagon Asset Management sold 1,848,454 Amicus Therapeutics shares in Q4 2025, an estimated $14.6M.
  • Assenagon Asset Management first reported a position in Amicus Therapeutics in Q4 2018 and held it in 12 quarters.
  • Assenagon Asset Management's Amicus Therapeutics position peaked at $39.1M in Q1 2019.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Assenagon Asset Management's 13F filing for Q4 2025, filed 9 Jan 2026.